Keyword: Securities and Exchange Commission (SEC)
News
23.03.2016
- J. Michael Pearson has stepped down as CEO of Canada-based Valeant Pharmaceuticals two months after returning from a medical leave, as the company’s stock continues to bleed. One...
News
04.03.2016
- Despite recent reports of progress in aligning production segments and geographic locations, the merger of Dow and DuPont may not take shape as fast as the future partners...
News
03.03.2016
- Canada-based, US-managed drug firm Valeant Pharmaceuticals has confirmed it is under another investigation by the Securities and Exchange Commission (SEC), the latest in a string...
News
24.08.2015
- Rayonier Advanced Materials has filed a lawsuit against Eastman Chemical in a dispute over their purchase and supply agreement for specialty cellulose products. The action, which...
